SPOTLIGHT -
Richard Adler, MD, FACS, reviews a patient case and discusses the ongoing discussion on how to define and identify dry eye disease.
HanAll Biopharma Co. announces initiation of phase III VELOS-4 trial for dry eye disease
(EyePod) From idea to impact: Navigating ophthalmic innovation
Study: CRISPR gene editing leads to improvements in vision for people with inherited blindness
EyePod: Integrating cutting-edge pipeline devices for enhanced cataract surgery
Investigation shows limited predictive ability for vision recovery in open globe injuries with NLP vision
Toric IOLs effectively correct some types of irregular astigmatism